Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026)

Incannex Healthcare (IXHL) posted quarterly Share-based Compensation of -$1.5 million for Q1 2026, down 252.88% year-on-year from $960201.3 in Q1 2025, and up 35.59% on a QoQ basis from -$2.3 million in Q4 2025.

Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Share-based Compensation for 4 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Share-based Compensation fell 252.88% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $177000.0 (down 94.0% YoY) and the FY2025 annual result came in at $2.6 million, down 97.71% from the prior year.
  • Share-based Compensation improved to -$1.5 million in Q1 2026 per IXHL's latest filing, from -$2.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for IXHL reached as high as $3.4 million in Q4 2023 and fell as low as -$2.3 million in Q4 2025.
  • A 4-year average of $725307.7 and a median of $459000.0 in 2024 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2024 — Share-based Compensation soared 5764.91% — and 2025, when it sank 423.91%.
  • Year by year, Share-based Compensation stood at $3.4 million in 2023, then plunged by 112.81% to -$435000.0 in 2024, then plunged by 423.91% to -$2.3 million in 2025, then jumped by 35.59% to -$1.5 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered -$1.5 million, -$2.3 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - -1.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.47 Mn
Mar 31, 2026 -1.47 Mn
Dec 31, 2025 -2.28 Mn
Dec 31, 2025 -2.28 Mn
Sep 30, 2025 2.63 Mn
Sep 30, 2025 2.63 Mn
Jun 30, 2025 1.30 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 -416,000.00
Mar 31, 2025 -416,000.00
Dec 31, 2024 -435,000.00
Dec 31, 2024 -435,000.00
Sep 30, 2024 459,000.00
Sep 30, 2024 459,000.00
Jun 30, 2024 3.34 Mn
Jun 30, 2024 3.34 Mn
Mar 31, 2024 2.12 Mn
Mar 31, 2024 2.12 Mn
Dec 31, 2023 3.40 Mn
Dec 31, 2023 3.40 Mn